The DOI matches its Crossref record.
Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon
Open accessAbstract
MAP30 is an anti-HIV plant protein that we have identified and purified to homogeneity from bitter melon (Momordica charantia). It is capable of acting against multiple stages of the viral life cycle, on acute infection as well as replication in chronically infected cells. In addition to antiviral action, MAP30 also possesses anti-tumor activity, topological inactivation of viral DNA, inhibition of viral integrase and cell-free ribosome-inactivation activities. We have cloned and expressed the MAP30 gene. The objective of this study is to characterize recombinant MAP30 (re-MAP30) and to determine its anti-HIV, anti-tumor and other activities. We report here that re-MAP30 inhibits HIV-1 and certain human tumors to the same extent as its native counterpart, natural MAP30 (nMAP30). The anti-HIV activity was measured by quantitative focal syncytium formation on CEM-ss cell monolayers, viral core protein p24 expression and viral-associated reverse transcriptase activity in HIV-1-infected H9 cells. The anti-tumor activity was measured by metabolic labeling of protein synthesis in tumor cells. In the dose range of the assay, re-MAP30 exhibits little toxicity to the uninfected viral target cells and other normal human cells. Identical to nMAP30, re-MAP30 is also active in topological inactivation of viral DNA, inhibition of viral DNA integration and cell-free ribosome inactivation. The cloning and expression of the gene encoding biologically active re-MAP30 provides an abundant source of homogeneous material for clinical investigations, as well as structure-function studies of this novel antiviral and anti-tumor agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Plant Products as Antimicrobial Agents
Cowan, M. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.564 · Cited by 9,043
Pharmacological actions and potential uses of Momordica charantia: a review
Grover, J. K., & Yadav, S. P. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.03.035 · Cited by 821
Recent Advances in Momordica charantia: Functional Components and Biological Activities
Jia, S., Shen, M., Zhang, F., & Xie, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122555 · Cited by 421
Development of botanicals to combat antibiotic resistance
Gupta, P. D., & Birdi, T. J. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.05.004 · Cited by 371
Willcox, D. C., Willcox, B. J., Todoriki, H., & Suzuki, M. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718117 · Cited by 311
Metadata
- Authors
- Lee-Huang, S., Huang, P. L., Chen, H.-C., Huang, P. L., Bourinbaiar, A., Huang, H. I., & Kung, H.-F.
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 1995-08
- Volume
- 161
- Issue
- 2
- Pages
- 151-156
- ISSN
- 0378-1119 (ISSN-L)
- OpenAlex
- W2032856082
- Cited by
- 176
- References
- 0
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. https://app.cochat.ai/papers/10.1016/0378-1119(95)00186-a
- The paper
- Lee-Huang, S., Huang, P. L., Chen, H.-C., Huang, P. L., Bourinbaiar, A., Huang, H. I., & Kung, H.-F. (1995). Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene. https://doi.org/10.1016/0378-1119(95)00186-a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.